Skip to content

Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality

Effects of Preoperative Scalp Nerve Block on Postoperative Recovery Quality in Patients Undergoing Excision of Intracranial Meningioma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03648034
Enrollment
144
Registered
2018-08-27
Start date
2018-09-18
Completion date
2019-11-30
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningioma

Brief summary

Patients undergoing elective meningeoma resection surgery will be randomly assigned to one of the following two groups. After anesthesia induction but before skull-pin insertion, one group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline. The patients' postoperative recovery quality, which is evaluated by KPS score, peri-operative inflammatory responses, and post-operative pain degree will be evaluated and compared between the two groups.

Detailed description

Patients undergoing elective meningeoma resection surgery will be randomly assigned to one of the following two groups. After anesthesia induction but before skull-pin insertion, one group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline. The patients' KPS scores at 3d after surgery and at discharge, serum levels of TNF-α、IL-6,IL-1β at 24h after surgery, satisfaction score after recovery, and VAS scores at 1, 2, 3 days post-surgery will be evaluated and compared between the two groups.

Interventions

PROCEDUREropivacaine

To perform scalp nerve blocks with ropivacaine

PROCEDUREsaline

To perform scalp nerve blocks with saline

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. 18-75 years old; 2. BMI 18-28 kg/m2; 3. ASA Physical Status 1-2; 4. Clinical diagnosis of primary Meningeoma and will have elective Meningeoma Resection Surgery; 5. With an estimated surgery time of less than 4h; 6. The incision will be conducted at the frontal, top or the temperal skull.

Exclusion criteria

1. A history of previous brain surgery; 2. Severe systemic disease (heart, lung, kidney, or immune system); 3. Nerval or mental disorders; 4. A history of addiction to opioids; 5. Allergic to ropivacaine; 6. Infection at block site or severe systemic infection; 7. Refuse to attend the trial.

Design outcomes

Primary

MeasureTime frameDescription
KPS score7 days post-surgeryKarnofsky performance score (KPS) allows patients to be classified as to their functional impairment. The total scale range is 0-100. The lower the KPS score, the worse the survival for most serious illnesses.

Secondary

MeasureTime frameDescription
serum TNF-α levelsat 1h and 24h post-surgeryan inflammatory mediator that reflects systemic inflammation
serum IL-6 levelsat 1h and 24h post-surgeryan inflammatory mediator that reflects systemic inflammation
serum IL-1β levelsat 1h and 24h post-surgeryan inflammatory mediator that reflects systemic inflammation
Iowa Satisfaction with Anesthesia Scale (ISAS)1 hour after the surgery is finishedIowa Satisfaction with Anesthesia Scale (ISAS) comprises of 11 items to measure patient satisfaction after surgery. The total scale range is -33-+33. The higher the ISAS score, the better the satisfaction level.
white blood cellat 24 h after surgeryserum white blood cell count
KPS score3 days post-surgeryKarnofsky performance score (KPS) allows patients to be classified as to their functional impairment. The total scale range is 0-100. The lower the KPS score, the worse the survival for most serious illnesses.
VAS scoreat 1, 2 and 3 days post-surgeryThe visual analogue scale or visual analog scale (VAS) measures the average intensity of pain in the past on a 0-to-10 scale, where 0 = No pain and 10 = Pain as intense as you can imagine.
pain-relief medicationsat 1, 2 and 3 days post-surgeryamounts of pain-relief medications
Hospitalization Daysup to 30 dayslength of hospitalization
out of pocket expenditure for hospitalisationhospital discharge/up to 30 daysThis reflects how much money the patient spends during hospitalisation
complicationswithin 30 days after surgeryincidence of intracranial infection
serum levels of CRPat 24 h after surgeryinflammatory responses

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026